Results 81 to 90 of about 204,846 (354)

Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C‐reactive protein for early detection of malignant tumors in dogs

open access: yesJournal of Veterinary Internal Medicine
Background Although the importance of early diagnosis of malignant tumors is a major concern, an easily accessible in‐house method has not been established.
Yoonhee Kim   +12 more
doaj   +1 more source

Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis

open access: yesPediatrics and Neonatology, 2021
Between 10% and 20% of neonates born to mothers with myasthenia gravis (MG) develop neonatal MG due to the transfer of maternal autoantibodies across the placenta.
Shigeo Iijima
doaj   +1 more source

Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance

open access: yesClinical Chemistry, 2019
BACKGROUND: The Islet Autoantibody Standardization Program (IASP) aims to improve the performance of immunoassays measuring type 1 diabetes (T1D)-associated autoantibodies and the concordance of results among laboratories.
V. Lampasona   +47 more
semanticscholar   +1 more source

Correlation of autoantibody-positivity with genotypes of PTPN22 gene functional variant (C1858C, rs2476601) in Kuwaiti TIDM patients.

open access: yes, 2018
ICA, Islet cell autoantibody; GADA, glutamic acid decarboxylase autoantibody; INS, insulin autoantibody.
Majedah A. Rasoul (5429723)   +4 more
core   +1 more source

Autoantibody-negative rheumatoid arthritis: still a challenge for the rheumatologist

open access: yes, 2023
Increased research over the past 30 years has greatly improved the understanding of the pathophysiological mechanisms and clinical aspects of autoantibody-positive rheumatoid arthritis, resulting in improved management and outcomes.
De Stefano, Ludovico   +4 more
core   +1 more source

Utility of the APE2 Score as a Diagnostic Tool for Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To retrospectively evaluate the diagnostic performance of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score relative to clinician‐adjudicated autoimmune encephalitis (AE) and the Graus criteria in a tertiary neuroimmunology referral cohort, including antibody‐negative AE.
Bijoya Basu   +3 more
wiley   +1 more source

Individual and stable autoantibody repertoires in healthy individuals

open access: yesAutoimmunity, 2019
In the era towards precision medicine, we here present the individual specific autoantibody signatures of 193 healthy individuals. The self-reactive IgG signatures are stable over time in a way that each individual profile is recognized in longitudinal ...
Maja Neiman   +12 more
semanticscholar   +1 more source

Characteristics of relatives at high autoantibody-inferred risk (HR) (IA-2A+ or ZnT8A+ plus ≥ 1 other autoantibody) [9] according to progression rate to diabetes.

open access: yes, 2016
Characteristics of relatives at high autoantibody-inferred risk (HR) (IA-2A+ or ZnT8A+ plus ≥ 1 other autoantibody) [9] according to progression rate to diabetes.
Ilse Vermeulen (3373907)   +13 more
core   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini   +9 more
wiley   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Home - About - Disclaimer - Privacy